Dogwood Therapeutics, Inc. (DWTX) earnings
DWTX earnings moved a median of +1.02% by the close. Quarterly and annual DWTX reports and results, each read against the price at its own news timestamp. Back to the DWTX overview →
18 measured DWTX earnings events.
Where these DWTX earnings landedvs 18 measured DWTX earnings reactions
| Middle 50% of DWTX earnings reactions | -2.90% to +3.83% |
|---|---|
| Median reaction (to close) | +1.02% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 DWTX earnings events with a measured close landed between -2.90% and +3.83%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Dogwood Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +7.56% | |
| Dogwood Therapeutics Announces Third Quarter 2026 Financial Results | Press release | -0.40% | -0.95% | |
| Form 10-Q Dogwood Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.50% | +8.04% | |
| Dogwood Therapeutics Announces Second Quarter 2026 Financial Results | Press release | +0.00% | +3.13% | |
| Form 10-Q Dogwood Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -5.18% | |
| Dogwood Therapeutics Announces First Quarter 2026 Financial Results | Press release | +2.23% | +10.62% | |
| Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 | Press release | -0.30% | -4.88% | |
| Form 10-K Dogwood Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.03% | -6.38% | |
| Form 10-Q Dogwood Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.15% | |
| Dogwood Therapeutics Reports Third Quarter 2025 Financial Results | Press release | -0.55% | -5.46% | |
| Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 | Press release | -1.46% | +7.61% | |
| Dogwood Therapeutics Reports Second Quarter 2025 Financial Results | Press release | -3.83% | -3.23% | |
| Form 10-Q Dogwood Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.70% | +1.43% | |
| Dogwood Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025 | Press release | +0.00% | -1.94% | |
| Form 10-Q Dogwood Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -1.41% | |
| Dogwood Therapeutics Announces First Quarter 2025 Financial Results | Press release | +0.22% | +0.89% | |
| Dogwood Therapeutics Announces Third Quarter 2024 Financial Results | Press release | +0.00% | +3.01% | |
| Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024 | Press release | — | +4.07% |
Keep exploring
More DWTX: analyst actions → · SEC filings → · DWTX overview →